{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "go:GO:0009058",
      "entity_text" : "biosynthesis",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P20142",
      "entity_text" : "PGC",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Consistent with this interpretation, while the PGC morphology defect could be strongly suppressed by reducing the dosage of isoprenoid biosynthesis genes, suppression of the PGC number defect in stage 5 embryos was much weaker (XREF_FIG B).",
  "reading_complete" : "2020-08-04T11:17:29Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T11:15:46Z",
  "trigger" : "suppressed",
  "evidence" : [ "PGC morphology defect could be strongly suppressed by reducing the dosage of isoprenoid biosynthesis" ],
  "pmc_id" : "4542285",
  "score" : 0
}